References
- Agrawal A, Sharma M, Rai SK, et al (2008). The effect of the aqueous extract of the roots of Asparagus racemosus on hepatocarcinogenesis initiated by diethylnitrosamine. Phytother Res, 22, 1175-82. https://doi.org/10.1002/ptr.2391
- Battu GR, Kumar BM (2010). Anti-inflammatory activity of leaf extract of asparagus racemosus willd. Int J Chem Sci, 8, 1329-38.
- Bhatnagar M, Sisodia SS, Bhatnagar R (2005). Antiulcer and anti-oxidant activity of Asparagus racemosus Willd and Withania somnifera Dunal in rats. Ann NY Acad Sci, 1056, 261-78. https://doi.org/10.1196/annals.1352.027
- Bhutani KK, Paul AT, Fayad W, Linder S (2010). Apoptosis inducing activity of steroidal constituents from Solanum xanthocarpum and Asparagus racemosus. Phytomedicine, 17, 789-93. https://doi.org/10.1016/j.phymed.2010.01.017
- Bousserouel S, Le Grandois J, Gosse F, et al (2013). Methanolic extract of white asparagus shoots activates TRAIL apoptotic death pathway in human cancer cells and inhibits colon carcinogenesis in a preclinical model. Int J Oncol, 43, 394-404.
- Cragg GM, Newman DJ (2005). Plants as a source of anti-cancer agents. J Ethnopharmacol, 100, 72-9. https://doi.org/10.1016/j.jep.2005.05.011
- Diwanay S, Gautam M, Patwardhan B (2004). Cytoprotection and Immunomodulation in Cancer Therapy. Curr Med Chem Anticancer Agents, 4, 479-90. https://doi.org/10.2174/1568011043352704
- Gautam M, Diwanay S, Gairola S, et al (2004). Immunoadjuvant potential of Asparagus racemosus aqueous extract in experimental system. J Ethnopharmacol, 91, 251-5. https://doi.org/10.1016/j.jep.2003.12.023
- Gautam M, Saha S, Bani S, et al (2009). Immunomodulatory activity of Asparagus racemosus on systemic Th1/Th2 immunity: Implications for immunoadjuvant potential. J Ethnopharmacol, 121, 241-7. https://doi.org/10.1016/j.jep.2008.10.028
-
Hannan JM, Marenah L, Ali L, et al (2007). Insulin secretory actions of extracts of Asparagus racemosus root in perfused pancreas, isolated islets and clonal pancreatic
$\beta$ -cells. J Endocrinol, 192, 59-168. - Harborne JB (1973). Phytochemical Methods. Chapman and Hall Ltd., London, 49-188.
- Hayes PY, Jahidin AH, Lehmann R, et al (2006). Structural revision of shatavarins I and IV, the major components from the roots of Asparagus racemosus. Tetrahedron Lett, 47, 6965-9. https://doi.org/10.1016/j.tetlet.2006.07.121
- Hayes PY, Jahidin AH, Lehmann R, et al (2008). Steroidal saponins from the roots of Asparagus racemosus. Phytochemistry, 69, 796-804. https://doi.org/10.1016/j.phytochem.2007.09.001
- Ito TK, Ishii G, Chiba H, Ochiai A (2007). The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells. Oncogene, 8, 7194-203.
-
Kamat JP, Boloor KK, Devasagayam TPA, Venkatachalam SR (2000). Antioxidant properties of Asparagus racemosus against damage induced by
$\gamma$ -radiation in rat liver mitochondria. J Ethnopharmacol, 71, 425-35. https://doi.org/10.1016/S0378-8741(00)00176-8 - Kongkaneramit L, Witoonsaridsilp W, Peungvicha P, et al (2011). Antioxidant activity and antiapoptotic effect of Asparagus racemosus root extracts in human lung epithelial H460 cells. Exp Ther Med, 2, 143-8.
- Liu FT, Agrawal SG, Gribben JG, et al (2008). Bortezomib blocks Bax degradation in malignant B cells during treatment with TRAIL. Blood, 111, 2797-805. https://doi.org/10.1182/blood-2007-08-110445
- Macher-Goeppinger S, Roth W, Wagener N, et al (2012). Molecular heterogeneity of TFE3 activation in renal cell carcinomas. Mod Pathol, 25, 308-15.
- Meena J, Ojha R, Muruganandam AV, Krishnamurthy S (2011). Asparagus racemosus competitively inhibits in vitro the acetylcholine and monoamine metabolizing enzymes. Neurosci Lett, 503, 6-9. https://doi.org/10.1016/j.neulet.2011.07.051
- Mohan S, Mohanasenthil, Paul S, Shroff S, Venkatesan V (2009). Interleukin-4-receptor alpha gene polymorphism and the risk of renal cell carcinoma in a South Indian population. Asian Pac J Cancer Prev, 10, 295-8.
- Parihar MS, Hemnani T (2004). Experimental excitotoxicity provokes oxidative damage in mice brain and attenuation by extract of Asparagus racemosus. J Neural Transm, 111, 1-12. https://doi.org/10.1007/s00702-003-0069-8
- Sekine T, Ikegami F, Fukasawa N (1995). Structure and relative stereochem- istry of a new polycyclic alkaloid, AsparagamineA, showing anti-oxytocin activity, isolated from Asparagus racemosus. J Chem Soc Perkin Trans, 4, 391-3.
- Sekine T, Fukasawa N, Murakoshi I, Ruangrungsi N (1997). A 9,10-dihydrophenanthrene from Asparagus racemosus. Phytochemistry, 44, 763-4. https://doi.org/10.1016/S0031-9422(96)00579-1
- Shao Y, Chin CK, Ho CT, et al (1996). Anti-tumor activity of the crude saponins obtained from asparagus. Cancer Lett, 104, 31-6. https://doi.org/10.1016/0304-3835(96)04233-4
- Sidhar SK, Clark J, Gill S, et al (1996). The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol Genet, 5, 1333-8. https://doi.org/10.1093/hmg/5.9.1333
- Sofowora A (1993). Medicinal Plants and Traditional Medicine in Africa. Spectrum Books Ltd., Ibadan, Nigeria, 191-289.
- Thakur M, Connellan P, Deseo MA, et al (2012). Characterization and in vitro immunomodulatory screening of fructooligosaccharides of Asparagus racemosus Willd. Int J Biol Macromol, 50, 77-81. https://doi.org/10.1016/j.ijbiomac.2011.09.027
- Tanriverdi O (2013). Review on targeted treatment of patients with advanced-stage renal cell carcinoma: a medical oncologist's perspective. Asian Pac J Cancer Prev, 14, 609-17. https://doi.org/10.7314/APJCP.2013.14.2.609
- Trease GE, Evans WC (1989). Pharmacognosy. 11th ed., Bailliere Tindall, London, 45-50.
- Weterman MA, van Groningen JJ, den Hartog A, Geurts van Kessel A (2001). Transformation capacities of the papillary renal cell carcinoma-associated PRCCTFE3 and TFE3PRCC fusion genes. Oncogene, 20, 1414-24. https://doi.org/10.1038/sj.onc.1204213
- Wiboonpun N, Phuwapraisirisan P, Tip-pyang S (2004). Identification of antioxidant compound from Asparagus racemosus. Phytother Res, 18, 771-3. https://doi.org/10.1002/ptr.1526
Cited by
- Aqueous Extract of Anticancer Drug CRUEL Herbomineral Formulation Capsules Exerts Anti-proliferative Effects in Renal Cell Carcinoma Cell Lines vol.16, pp.18, 2016, https://doi.org/10.7314/APJCP.2015.16.18.8419
- vol.51, pp.11-12, 2017, https://doi.org/10.1080/10715762.2017.1395419
- Sodium butyrate induces cell death by autophagy and reactivates a tumor suppressor gene DIRAS1 in renal cell carcinoma cell line UOK146 vol.54, pp.4, 2018, https://doi.org/10.1007/s11626-018-0239-5
- Monensin induces cell death by autophagy and inhibits matrix metalloproteinase 7 (MMP7) in UOK146 renal cell carcinoma cell line pp.1543-706X, 2018, https://doi.org/10.1007/s11626-018-0298-7